PuREC Partners With Mochida Pharmaceutical To Manufacture Its High-Purity Mesenchymal Stem Cells Towards The Treatment Of Metabolic Bone Diseases May 18, 2023
Metagen Therapeutics Announces Initial Closing of Series A, Introducing an Unprecedented Potential of Microbiome Therapeutics April 5, 2023
SONIRE Therapeutics Begins a Randomized Phase 2 Clinical Study For Patients With Unresectable Pancreatic Cancer February 3, 2023
RIN Institute Announces First-In-Human Dose of RN-1101, A Monoclonal Antibody For Colorectal Cancer Treatment In Phase I Clinical Trial February 2, 2023
STORM Therapeutics Announces Series B Financing To Advance First-in-class Programs For Cancer And Other Diseases December 14, 2022
Additional investment in SONIRE Therapeutics, which promotes the development of cancer treatment devices using High-Intensity Focused Ultrasound (HIFU) November 30, 2022
Metagen Therapeutics Announces Pre-Series A Funding For Its Microbiome Drug Discovery October 6, 2022
Cellshoot Therapeutics Develops Groundbreaking Cell Analysis Technology For New Drug Discovery, Announcing 230M JPY In Seed Funding Round July 29, 2022
Fast Track Initiative is Selected as a Certified VC Fund by AMED to Propel the Japanese Drug Development Ecosystem June 30, 2022
LUCA Science Raises 30.3M USD For Mitochondrial Therapy in Oversubscribed Series B Financing June 6, 2022
